Advertisement
Articles
Subscribe to Drug Discovery & Development Articles

The Lead

Germany's Pharmaceutical Market Value will Crawl to $65B by 2020

March 26, 2015 | by Joshua Owide, Director of Healthcare Industry Dynamics, GlobalData | Comments

Germany is a mature market with high healthcare expenditure and pharmaceutical production. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Men’s Heart Disease Partly Due to Low Estrogen

March 26, 2015 8:52 am | by Cynthia Fox, Science Writer | Comments

One reason men have more heart disease than women is the very fact that they are men, reports Harvard University endocrinologist Evelyn Yu, M.D., MS.c. Both men’s higher testosterone levels and their lower estrogen levels, play a role. Read more...

TOPICS:

Sepsis-Specific Treatment Market Will Expand from 2016, Reach $354M by 2021

March 25, 2015 12:28 pm | by Marc C. Hansel, Ph.D., GlobalData Infectious Diseases Analyst | Comments

GlobalData's latest report states that this growth will be driven by the increased uptake of novel therapies. Read more...

TOPICS:

Non-FDA Approved Hormone Therapies on the Rise

March 25, 2015 9:36 am | by Cynthia Fox, Science Writer | Comments

Use of potentially risky, non-FDA approved hormone therapies may soon be as common as use of FDA-approved hormone therapies, according to a study by University of Virginia gynecology researcher JoAnn Pinkerton. Read more..

TOPICS:
Advertisement

Blueprint Medicine Files for IPO

March 25, 2015 9:30 am | by Ryan Bushey, Associate Editor | Comments

The biotech firm is making a big bet on the success of its precision therapies. Read more...

TOPICS:

Gilead Issues Safety Alert over Hepatitis C, Heart Drug Combination

March 24, 2015 12:03 pm | by Ryan Bushey, Associate Editor | Comments

Taking these medications together is ill-advised. Read more...

TOPICS:

Capturing the Living Picture of Cancer: Proteomic Testing in the Clinical Lab

March 19, 2015 12:46 pm | by Richard Hockett, M.D., Chief Medical Officer at Biodesix, a molecular diagnostics company | Comments

If genetic sequencing provides the script of life, then proteomics is the live video capturing biology in action. Proteomics moves beyond the static information provided by genomics and tells the story in real-time of proteins, which result from the individual genes within a cell. Read more...

TOPICS:

Where is the Money in Biosimilars?

March 18, 2015 9:11 am | by Daniel N. Galbraith, Ph.D., BioOutsource Ltd | Comments

In the past 10 years biosimilars have held strong in the biologics industry’s headlines. These products were once thought impossible to approve in regulated markets because the sheer complexity of producing these large, complex proteins can result in “robustness” issues. Read more...

TOPICS:

Sickle Cell Drug Offers “Overwhelming” Gains as “Exciting” Stem Cell Trial Starts

March 16, 2015 3:58 pm | by Cynthia Fox, Science Editor | Comments

A clinical trial of the most common sickle cell anemia drug, hydroxyurea, was halted a year early this winter because of “overwhelming evidence of benefit,” reported University of Nebraska Medical Center pediatric researcher Stephen Obaro, M.D., Ph.D., in The Lancet. Read more...

TOPICS:
Advertisement

d-Methadone: A Novel Approach for Neuropathic Pain

March 12, 2015 8:45 am | by Eliseo Salinas, MD, MSc, President and Chief Scientific Officer, Relmada Therapeutics | Comments

At a time when opioid abuse and addiction are making headlines, a new molecule is being studied to treat neuropathic pain without such negative effects. Read more...                        

TOPICS:

Endo Proposes Takeover Bid for Salix Pharmaceuticals

March 11, 2015 2:34 pm | by Ryan Bushey, Associate Editor | Comments

Endo is trying to upset the agreement Valeant Pharmaceuticals made last month to buy Salix. Read more...

TOPICS:

Stanford Showcases New App for Studying Heart Health

March 11, 2015 10:13 am | by Ryan Bushey, Associate Editor | Comments

Stanford is one of the institutions Apple teamed up with to launch this program. Read more...                           

TOPICS:

Breakthrough Therapies Target Cancers in 2015

March 11, 2015 8:57 am | by Bevin Fletcher, Associate Editor, Bioscience Technology | Comments

Getting a new drug to market is difficult, but the U.S. Food and Drug Administration (FDA) offers a number of ways to help the process along for promising drugs that have potential against serious diseases. Read more...

TOPICS:

FDA: Seizure, Alcohol Risk with Pfizer’s Chantix

March 10, 2015 11:59 am | by Stephanie Guzowski, Editor | Comments

The U.S. Food and Drug Administration (FDA) has determined it will not reduce the severity of its black-box warning about side effects associated with Pfizer’s smoking-cessation drug. Read more...                                                

TOPICS:

Collegium Pharma Raises $50M to Further Develop Abuse-Deterrent Painkiller

March 10, 2015 11:52 am | by Ryan Bushey, Associate Editor | Comments

Technology has made it very hard to crush or melt this drug. Read more...                               

TOPICS:

AbbVie to Buy Pharmacyclics for $21 Billion

March 6, 2015 3:18 pm | by Ryan Bushey, Associate Editor | Comments

Investors did not seem pleased about this deal. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading